Monograph OTCs Subject To Adverse Event Reporting Under Hatch Bill
This article was originally published in The Rose Sheet
Executive Summary
Firms that make, pack or distribute over-the-counter drugs approved under monographs will have to be in compliance with a new adverse event reporting law by December 2007 if President George W. Bush signs a recently passed bill